Polymorphisms in Genes Hydroxysteroid-Dehydrogenase-17b Type 2 and Type 4 and Endometrial Cancer Risk

Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2010.11.014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

11?-Hydroxysteroid Dehydrogenase Type 1 in Obesity and Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

Genetic Polymorphisms in Obesity-Related Genes and Endometrial Cancer Risk

Cancer
Cancer ResearchOncology
2011English

Rac1 GTPase Regulates 11β Hydroxysteroid Dehydrogenase Type 2 and Fibrotic Remodeling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Characterisation of the Cancer-Associated Glucocorticoid System: Key Role of 11β-Hydroxysteroid Dehydrogenase Type 2

British Journal of Cancer
Cancer ResearchOncology
2017English

Altered Expression of 17‑β‑hydroxysteroid Dehydrogenase Type�2 and Its Prognostic Significance in Non‑small Cell Lung Cancer

International Journal of Oncology
Cancer ResearchOncology
2020English

Edema, Enigma: 11 B-Hydroxysteroid Dehydrogenase Type 2 Inhibition by Sweetener “Stevia”

Open Journal of Endocrine and Metabolic Diseases
2012English

Transcriptional Regulation of Type 11 17β-Hydroxysteroid Dehydrogenase Expression in Prostate Cancer Cells

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2011English

Clinical Perspectives in Congenital Adrenal Hyperplasia Due to 3β-Hydroxysteroid Dehydrogenase Type 2 Deficiency

Endocrine
2019English

Polymorphisms in Metallothionein-1 and -2 Genes Associated With the Risk of Type 2 Diabetes Mellitus and Its Complications

American Journal of Physiology - Endocrinology and Metabolism
EndocrinologyPhysiologyMetabolismDiabetes
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy